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Patients with obstructive jaundice frequently suffer postoperative complications. We have investigated
the relationship of obstructive jaundice to the neutrophil oxidase response and the "priming" of the
response by the cytokines TNFa, interleukin-1 (IL-1), IL-6, and IL-8. On stimulation with f-met-leu-
phe (fmlp), the respiratory burst in neutrophils from jaundiced patients was greatly increased compared
with controls (p < 0.01), jaundiced patients having the highest respiratory burst levels were those with
the poorest prognosis. Neutrophils from controls were primed by all the cytokines tested, whereas
"jaundiced" cells were primed only by IL-1, and not by TNFa, IL-6, or IL-8, which in fact produced
slight inhibition. We conclude that neutrophils from obstructive jaundiced patients have raised oxidative
responses which may be due to "pre-priming" in oivo by cytokines, such as IL-6, IL-8, or TNFa. This
exaggeration of the oxidative response in circulating neutrophils may contribute to the peri-operate
complications of patients with obstructive jaundice.
KEY WORDS: Neutrophils, respiratory burst, obstructive jaundice, tumor necrosis factor,
Interleukin-1, Interleukin-6, Interleukin-8
Abbreviations" Fmlp: f-met-leu-phe, GM-CSF: granulocyte-macrophage colony-stimulating factor,
IFN: interferon, IL: interleukin, TGF/3: transforming growth factor beta, TNF: tumor necrosis factor,
HU r TNFa: Human recombinant tumor necrosis factor alpha
INTRODUCTION
Neutrophils are the largest population of immune cells in the body and play a key
role in combating bacterial infections. There is however increasing evidence that,
apart from killing pathogens, neutrophils may also cause tissue damage in some
pathological conditions such as trauma1, sepsis2, adult respiratory distress syn-
drome (ARDS)3, and rheumatoid arthritis4. Neutrophils secrete toxic products,
such as hydrolytic enzymes and toxic metabolites of oxygen, which have the
potential to cause damage to neighbouring cells and extracellular matrix. Recently,
a number of cytokines have been shown to cause "priming" of neutrophils; a state
in which the neutrophils are "prepared" to act upon a secondary stimulus.
Treatment of neutrophils with some cytokines, including tumor necrosis factor
56 alpha (TNFa)’, interleukin-1 (IL-1), interleukin-6 (IL-6) interleukin-8
910 11 (IL-8) granulocyte-macrophage colony-stimulating factor (GM-CSF) trans-
forming growth factor-beta (TGF-/3)
12 or interferon-gamma (IFN7)
13 causes an
increased respiratory burst on stimulation with such agents as the peptide, f-met-
leu-phe (fmlp). Since the circulating levels of these cytokines are increased in
critically ill patients and as they can increase the neutrophil oxidative responses,
they may exacerbate neutrophil-induced tissue damage
x’2,14,a5 in certain patients.
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Obstructive jaundice patients frequently suffer postoperative complications,
such as liver and renal dysfunction16’17. It has been shown that these patients have
increased levels of circulating endotoxin, a potent stimulant of monocyte cytokine
production18’19. Furthermore, peripheral blood monocytes from these patients have
an increased capacity to produce tumor necrosis factor and interleukin-6z.
The aims of this study were therefore to establish, in jaundiced patients, the
relationship between the neutrophils’ oxidative response, their sensitivity to "prim-
ing" by cytokines, TNFa, IL-1, IL-6, IL-8, and GM-CSF and the immediate clinical
outcome of the patient. We report here that neutrophils from jaundiced patients
had a greatly increased oxidative response. We suggest that this may be due to
cytokine pre-priming of the neutrophils in oioo, as we also demonstrate that IL-6,
IL-8 and TNFa had no further priming effect on these cells.
PATIENTS AND MATERIALS
Twenty two patients with obstructive jaundice were included in this study with a
mean age of 65.3 + 4 years. The cause of the benign biliary obstruction was
gallstones (n 8) or benign biliary stricture (n 2), and of the malignant
obstruction cholangiocarcinoma (n 8) or pancreatic cancer (n 5). The control
group (n 18) included normal volunteers, non-jaundiced patients for elective
surgery (hernia repair, cholecystectomy, or colectomy for cancer) with a mean age
of 54.6 + 7 years. All the patients gave informed consent and no patients showed
evidence of sepsis. In controls, the white cell count was 6.9 + 0.4 106/ml, with
neutrophils 4.4 + 0.4 106/ml; and in the jaundiced group the white count was 8.0
+ 0.5 166/ml with neutrophils 6.0 + 0.5 106/ml, no patients were pyrexial.
Blood was taken before any other clinical intervention. Peripheral blood was
heparinised and processed within one hour. All stages of the separation were
carried out at 4 C to avoid activation of the cells. Plasma were kept for bile salt
assay (by a commercial kit" "Enzabile", from Nycomed, Norway). Neutrophils
were separated by dextran sedimentation, Ficoll-Hypaque separation and a hypo-
tonic technique to remove the contaminating erythrocytes. The isolated cells were
93-95% neutrophils with less than 2% monocyte contamination as determined by
non-specific esterase staining. The neutrophils were suspended in HEPES-buffered
Krebs medium (NaC1 120mM, KC1 4.8 mM, Mg2SO4 1.2 mM, KzHPO4 1.2 mM,
CaC12 1.3 mM, HEPES 25 mM, with 0.1% bovine serum albumin, pH 7.4) and
adjusted to 107 cell/ml for experiments.
The neutrophil respiratory burst was monitored using luminol-dependent chemi-
luminescence as previously described21. Briefly, neutrophils were preincubated in
the presence of luminol with or without cytokine for 10 minutes in a water bath
(37 C) and were then put into the luminometer to record their base line response.
Cells were then stimulated with fmlp (lpM) in the presence of cytochalasin B (5tg/
ml) and the respiratory burst was recorded. Neutrophil oxidative responses are
shown as luminescent counts per second (CPS) and the extent of priming calculated
from the following formula"
Priming Index (PI)=
CPS with cytokine- CPS without cytokine
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Human recombinant tumor necrosis factor alpha (Hu rTNFa) was kindly
provided by Dr N Matthews (Dept of Microbiology, UWCM), 1 ng being equal to
40 international units (the standard used was 87/650, NBSB, England) as assayed
by a standardised L929 bioassay22. Hu rTNFa was used at 100 pg/ml final
concentration. Recombinant GM-CSF (purchased from R&D Systems, Oxford,
England) was used at 5.0 ng/ml. Recombinant human IL-lfl (86/680) and IL-8 (89/
520) were kindly provided by NBSB, and were used at final concentrations of 100
U/ml and lng/ml respectively. Recombinant human IL-6 was a gift from Dr
Aarden, Amsterdam, Netherlands) and was used at 200 U/ml. All other materials
were purchased from Sigma (UK).
Student t-test was used for statistical analysis and p < 0.05 taken as significant.
Data are shown as mean + SEM.
RESULTS
1. Respiratory Burst of Neutrophils from Jaundiced Patients
The respiratory burst of neutrophils from jaundiced patients stimulated with fmlp
was 1532.4 + 301.8 CPS which was significantly higher than 643.4 + 117.4 CPS
obtained with the control group (p < 0.01) (Figure 1). The three highest responses
were from patients who died within 7 days of the test being performed. The mean
response of these three was massively increased compared with the rest of the
jaundiced patients (2154.9 + 309.6 CPS compared with 1137.6 + 141.0 CPS, p <
0.05).
There was no statistically significant difference between the basal oxidative
activity of neutrophils from control or from jaundiced patients (9.4 + 2.2 CPS and
12.8 + 4.5 CPS respectively).
2. Priming ofJaundiced Neutrophils by Cytokines
Incubation of neutrophils from controls with Hu rTNFa for 10 minutes, resulted in
an increased respiratory burst in response to fmlp, the mean priming index being
54%. However neutrophils from jaundiced patients failed to be primed by the same
treatment with Hu rTNFct, rather Hu rTNFa caused a slight inhibition of the
response, with the priming index being -18% (Figure 2). Similarly, although IL-8
(lng/ml) and IL-6 (200 U/ml) primed neutrophils from controls (priming index
53% and 20.0% respectively), the priming of neutrophils from obstructive jaundice
was reduced (priming index -25% and 9% respectively. (Figures 3 and 4).
In contrast, interleukin-1 had a significant priming effect on neutrophil oxidative
responses both from controls, priming index 35%, and from patients with
obstructive jaundice, priming index 15%; (Figure 5). The weak primer GM-CSF
(5ng/ml) primed to a lesser extent both the normal neutrophil respiratory burst,
priming index 17% (6 individuals tested) and the response of neutrophils from
two jaundiced patients where the priming index was 12.5%.
3. Neutrophil Responses and Biochemical Parameters
In the jaundiced group, the mean plasma bilirubin level was 151.8 + 31/zM/1, mean284 W.G. JIANG ET AL.
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Figure 1 Neutrophil oxidative responses from a typical control and a jaundiced patient (arrow
indicates where fmlp was added). (a)" neutrophils from a control showing the base line and respiratory
burst. (b): neutrophils from a jaundiced patient, the respiratory burst is much higher than occurs in
controls.
albumin level 34.8 + 1.9 g/l, mean alkaline phosphatase 708 + 192/M/1, and the
mean aspartate aminotransferase 87.9 + 19.7/M/1. Bile salt levels in the control
and jaundiced groups were 15.4 3.0/M/I and 68.9 + 14.5/M/1 respectively. The
neutrophil base line response showed a minimal correlation with the plasma bile
salt levels, r 0.41, p < 0.05, but the respiratory burst, (r 0.33, p > 0.05)did
not correlate. Other parameters (bilirubin and, enzyme levels) failed to show any
correlation with neutrophil responses.
DISCUSSION
Although neutrophils are important in combating bacterial infection, their over-
activation has been shown to be harmful to the host. This overactivation of
neutrophils may have a role in causing damage to the host in sepsis, trauma,
ARDS, and rheumatoid arthritis. From the results presented in this paper, we
suggest that neutrophil priming and activation may also play a key part in the effect
of obstructive jaundice on the host. We demonstrate here that the oxidativeNEUTROPHIL PRIMING BY CYTOKINES 285
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Figure 2 Neutrophil priming by Hu rTNF. Cells were cultured with TNF (100pg/ml) for 10 minutes and
then stimulated with fmlp in the presence of cytochalasin B. Neutrophils from controls (left) an r primed
by TNF, but cells from jaundiced patients are inhibited by TNF. Bars indicate mean + sem.
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Figure 3 Neutrophil priming by interleukin-8 at 1.0 ng/ml. Significant priming by IL-8 was observed
with control neutrophils. IL-8 has inhibitory effects on the cells from jaundiced patients. Bars indicate
mean + sem.286 W.G. JIANG ET AL.
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Figure 4 Neutrophil priming by interleukin-6 at 200 U/ml. IL-6 primes normal neutrophils, but cells
from jaundiced patients are less responsive. Bars indicate mean + sem.
1600
Chemiluminiscence (CPS)
1400
1200
1000
800
60O
400
200
A vs B, p<0.05
C vs D, p<0.05
A vs C, p<0.05
B vs D, p<0.05
Medium
Control
IL-1 Medium IL-1
Jaundice
Figure 5 Neutrophil priming by interleukin-lfl at 100 U/ml. Cells from both the control and the
jaundiced group are primed by IL-1. Bars indicate mean _+ sem.NEUTROPHIL PRIMING BY CYTOKINES 287
response of neutrophils from jaundiced patients is massively increased. Although
the group studied was not large enough to include a large number of critically ill
patients, the three patients who died shortly after testing showed an extremely high
level of oxidative response. It is not clear which is cause and effect in this situation
but this observation clearly warrants further study.
A number of neutrophil primers have been reported recently. Interleukin-1,
IL-6, IL-8, TNFa, TGFfl, IFN,, and GM-CSF all have the property of priming the
neutrophil oxidative response. We confirm the ability of IL-1, IL-6, IL-8, TNFa
and GM-CSF to prime the oxidative response of neutrophils in the control group.
We have also demonstrated that IL-8 and TNFa are potent primers whereas,
GM-CSF and IL-6 are relatively weak.
Neutrophils from jaundiced patients compared with controls show markedly
different responses. Although the oxidative responses were larger than in controls
the effect of the primers especially to IL-6, IL-8 and TNFa was small or nonexis-
tent. These data suggest that neutrophils from jaundiced patients may have been
previously exposed to these or other cytokines in oioo and are therefore "pre-
primed" before the experiment. This suggestion is consistent with previous obser-
vations that monocytes from patients with obstructive jaundice produce higher
levels of TNFa and IL-62 and the circulating levels of cytokines including TGFfl
are also higher in these patients23. Bemelmans4 has reported that mice with
obstructive jaundice have increased plasma levels of TNFa and IL-6. The possibi-
lity therefore exists that neutrophils from these patients may be primed by the
presence of cytokines liberated from activated monocytes in oioo, or possibly by
the increased circulating endotoxin levels that have been reported in these
patients18’19’5’’6. Indeed, a recent report shows that neutrophil activation is closely
related to the circulating level of interleukin-8 in patients with acute pancreatitis7.
The mechanisms by which prior exposure to cytokines may render neutrophils
insensitive to subsequent exposure are not yet fully established. However, activa-
tion of neutrophils by some stimuli, including fmlp, results in the "shedding" of
TNFa membrane receptors8,9. Furthermore, it has been reported that neutrophils
from patients with sepsis have reduced cytokine receptor numbers and decreased
binding capacities for the cytokines IL-6 and TNFa3. The possibility therefore
exists that activation of neutrophils in oioo leads to a reduction in cytokine receptor
number or binding capacity, rendering them insensitive to subsequent attempts to
further prime these cells with cytokines. Another possibility is that prolonged
exposure to cytokines renders them insensitive to their presence. In oitro prolonged
incubation of normal neutrophils with IL-3, IL-6, IL-8, and TNF has been reported
to initially enhance leukotriene release and then to "deactivate" this response31.
Neutrophils from jaundiced patients may thus be desensitized to certain cytokines
by their prolonged pre-exposure in the circulation.
The lack of desensitization to IL-1 and possibly GM-CSF suggests that either
these two cytokines are not elevated in jaundiced patients, or that the mechanisms
responsible for desensitisation to the other cytokines do not operate for these
cytokines. It is interesting to note that in contrast to the monocyte production of
the other cytokines, IL-1 production in jaundiced patients remain unchanged.
This study has therefore shown that neutrophils from patients with obstructive
jaundice have a greatly increased oxidative response, possibly due to prior
exposure to circulating cytokines, and that for patients with an especially high
oxidative response and desensitization to certain cytokines this might be potentially
harmful and effect their immediate prognosis.288 W.G. JIANG ET AL.
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